Clinical Trial Update: Efficacy and Safety of Favipiravir in Management of COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting efficacy and safety of favipiravir in managing COVID-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease

Drugs mentioned

• Favipiravir (favipiravir)

Snippet

Sponsor: Ain Shams University | Conditions: Coronavirus Disease (COVID-19) | Phase 3 | Status: COMPLETED